ZNF700 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.555800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.306800E-01
Normal-vs-Stage2
4.646000E-01
Normal-vs-Stage3
3.333400E-01
Normal-vs-Stage4
4.423600E-01
Stage1-vs-Stage2
5.734000E-01
Stage1-vs-Stage3
7.648000E-02
Stage1-vs-Stage4
4.268400E-01
Stage2-vs-Stage3
1.855230E-01
Stage2-vs-Stage4
8.420800E-01
Stage3-vs-Stage4
1.672020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.645000E-01
Normal-vs-AfricanAmerican
3.262600E-01
Normal-vs-Asian
4.688800E-01
Caucasian-vs-AfricanAmerican
9.031900E-02
Caucasian-vs-Asian
9.942200E-01
AfricanAmerican-vs-Asian
9.219800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.691400E-01
Normal-vs-Female
4.403600E-01
Male-vs-Female
4.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.024000E-01
Normal-vs-Age(41-60Yrs)
4.640000E-01
Normal-vs-Age(61-80Yrs)
4.501600E-01
Normal-vs-Age(81-100Yrs)
4.620000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.514800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.507800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.418800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.996600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.376400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.076600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.682400E-01
Normal-vs-Daily Drinker
4.054200E-01
Normal-vs-Weekly Drinker
1.585850E-01
Normal-vs-Occasional Drinker
4.926200E-01
Normal-vs-Social Drinker
4.506800E-01
Non Drinker-vs-Daily Drinker
2.573000E-01
Non Drinker-vs-Weekly Drinker
9.005600E-01
Non Drinker-vs-Occasional Drinker
7.617000E-01
Non Drinker-vs-Social Drinker
7.827600E-01
Daily Drinker-vs-Weekly Drinker
5.735000E-01
Daily Drinker-vs-Occasional Drinker
2.182400E-01
Daily Drinker-vs-Social Drinker
4.279600E-01
Weekly Drinker-vs-Occasional Drinker
7.607000E-01
Weekly Drinker-vs-Social Drinker
9.420600E-01
Occasional Drinker-vs-Social Drinker
6.159000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.307240E-01
Normal-vs-Grade 2
5.776900E-03
Normal-vs-Grade 3
6.260400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.985400E-01
Grade 1-vs-Grade 3
5.821200E-01
Grade 1-vs-Grade 4
1.307240E-01
Grade 2-vs-Grade 3
6.201000E-01
Grade 2-vs-Grade 4
5.776900E-03
Grade 3-vs-Grade 4
6.260400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.415400E-01
Normal-vs-NonDiabetic
4.499800E-01
Diabetic-vs-NonDiabetic
8.114600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.551600E-01
Normal-vs-NoPancreatitis
4.358800E-01
Pancreatitis-vs-NoPancreatitis
8.130200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.655400E-01
Normal-vs-N1
4.517000E-01
N0-vs-N1
7.413000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.057200E-01
Normal-vs-TP53-NonMutant
4.832400E-01
TP53-Mutant-vs-TP53-NonMutant
6.850000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
